Search for dissertations about: "Treatment adherence"
Showing result 21 - 25 of 269 swedish dissertations containing the words Treatment adherence.
-
21. Problematic medication use in headache - Epidemiology and qualitative aspects of medication overuse headache and non-adherence to prophylactic migraine treatment
Abstract : Aim: The aim was to analyze problematic medication use among persons with headache, focusing on overuse of acute medications, with subsequent medication overuse headache (MOH), and on underuse of prophylactic medication. Methods: Data in Studies I and II came from a population survey in which 44 300 Swedes were interviewed by telephone about headache and medication use. READ MORE
-
22. From Stenting to Preventing : Invasive and Long-term Treatment for Coronary Artery Disease in Sweden
Abstract : Coronary artery disease (CAD) is the leading cause of death worldwide. Treatment with coronary interventions, long-term treatment and life style changes can reduce symptoms and improve prognosis. READ MORE
-
23. Patients’ and Spouses’ Perspectives on Coronary Heart Disease and its Treatment
Abstract : Background: Lifestyle changes and drug treatment can improve the prognosis and quality of life for patients with coronary heart disease (CHD), but their co-operation with suggested treatment is often limited. The aim of this thesis was to study how patients and their spouses conceive CHD and its treatment. READ MORE
-
24. Factors influencing adherence to risk factor modification in patients with coronary heart disease
Abstract : Adherence to lifestyle modification and pharmacological treatment is of great importance in order to achieve maximum benefits of preventive measures after a cardiac event. Unfortunately, patients are neither adopting adequate lifestyle changes nor do they adhere to prescribed medication. READ MORE
-
25. Aspects on long-term treatment with tyrosine kinase inhibitors in Chronic myeloid leukemia
Abstract : Chronic myeloid leukemia (CML) is caused by the tyrosine kinase activity of the oncoprotein BCR-ABL. The introduction of tyrosine kinase inhibitors (TKIs) targeting BCR-ABL has profoundly changed the prognosis of CML. Currently, there are three TKIs approved for treatment of CML, imatinib, nilotinib and dasatinib. READ MORE